Ally Bridge Group (Ny) LLC Sarepta Therapeutics, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $141 Million
- Q3 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 72,000 shares of SRPT stock, worth $8.31 Million. This represents 6.39% of its overall portfolio holdings.
Number of Shares
72,000
Previous 73,500
2.04%
Holding current value
$8.31 Million
Previous $11.6 Million
22.57%
% of portfolio
6.39%
Previous 10.89%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
84.2MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.19 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.04 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$723 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$503 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$493 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.1B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...